CRNX Crinetics
- 47.200
- +0.420+0.90%
- 48.110
- +0.910+1.93%
Crinetics News
Crinetics Pharmaceuticals to Report First Quarter 2024 Financial Results on May 9, 2024
SAN DIEGO, May 02, 2024 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that it will report first quarter 2024 financial results on Thursday, May 9, 2024, after th
Crinetics(CRNX.US) Officer Sells US$639.26K in Common Stock
$Crinetics(CRNX.US)$ Officer Pizzuti Dana sold 14,375 shares of common stock on Apr 15, 2024 at an average price of $44.47 for a total value of $639.26K.Source: Announcement What is statement of chang
Crinetics Pharmaceuticals Insider Sold Shares Worth $639,256, According to a Recent SEC Filing
Dana Pizzuti, Chief Medical and Development Officer, on April 15, 2024, sold 14,375 shares in Crinetics Pharmaceuticals (CRNX) for $639,256. Following the Form 4 filing with the SEC, Pizzuti has contr
Crinetics Pharmaceuticals Insiders Sold US$2.4m Of Shares Suggesting Hesitancy
In the last year, many Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) insiders sold a substantial stake in the company which may have sparked shareholders' attention.
Form 144 | Crinetics(CRNX.US) Officer Proposes to Sell 639.31K in Common Stocks
SEC FILLINGS DISCLOSED/ Apr 15, $Crinetics(CRNX.US)$ Officer DANA J PIZZUTI intends to sell 14,375 shares of its common stock on Apr 15, with a total market value of approximately $639.31K. DANA J P
Express News | Crinetics Pharmaceuticals Announces April 2024 Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Crinetics(CRNX.US) Officer Sells US$2.01 Million in Common Stock
$Crinetics(CRNX.US)$ Officer Struthers Richard Scott sold 40,951 shares of common stock on Apr 4, 2024 at an average price of $49.17 for a total value of $2.01 million.Source: Announcement What is sta
Crinetics Pharmaceuticals Launches New Deferred Compensation Plan
Form 144 | Crinetics(CRNX.US) Officer Proposes to Sell 2.01 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Apr 4, $Crinetics(CRNX.US)$ Officer Struthers Richard Scott intends to sell 40,951 shares of its common stock on Apr 4, with a total market value of approximately $2.01 million
Express News | Live On CNBC, Michelle Ross Mentions Crinetics Pharmaceuticals As A GLP-1 Adjacent Play During Halftime Segment 'Opportunities In Biotech' Calling It Her "Best Biotech Idea"
Crinetics Pharmaceuticals Gains Amid Pitch at Sohn Charity Conference
Crinetics(CRNX.US) Director Sells US$811.65K in Common Stock
$Crinetics(CRNX.US)$ Director Okey Stephanie sold 17,500 shares of Common Stock on Mar 28, 2024 at an average price of $46.38 for a total value of $811.65K.Source: Announcement What is statement of ch
Form 144 | Crinetics(CRNX.US) Director Proposes to Sell 790.65K in Common Stocks
SEC FILLINGS DISCLOSED/ Mar 28, $Crinetics(CRNX.US)$ Director Okey Stephanie intends to sell 17,500 shares of its common stock on Mar 28, with a total market value of approximately $790.65K. Source
Express News | JMP Securities Reiterates Market Outperform on Crinetics Pharmaceuticals, Maintains $80 Price Target
Crinetics Pharmaceuticals Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 03/28/2024 79.13% JMP Securities → $80 Reiterates Market Outperform → Market Outperform 03/20/2024 23.15%
Insider Sell: COO Jeff Knight Sells 32,359 Shares of Crinetics Pharmaceuticals Inc (CRNX)
Crinetics(CRNX.US) Officer Sells US$1.43 Million in Common Stocks
$Crinetics(CRNX.US)$ Officer Knight Jeff E. sold 32,359 shares of Common Stocks on Mar 22, 2024 at an average price of $44.31 for a total value of $1.43 million.Source: Announcement What is statement
Crinetics Pharmaceuticals Insider Sold Shares Worth $1,433,675, According to a Recent SEC Filing
Jeff E. Knight, Chief Operating Officer, on March 22, 2024, sold 32,359 shares in Crinetics Pharmaceuticals (CRNX) for $1,433,675. Following the Form 4 filing with the SEC, Knight has control over a t
Insider Sell: Chief Medical and Development Officer Dana Pizzuti Sells 15,089 Shares of ...
Director Matthew Fust Sells 60,000 Shares of Crinetics Pharmaceuticals Inc (CRNX)
Analysis
Price Target
No Data
